Research Training Grants & Fellowships
Research is the key to the future for people with hard to control seizures -- as many as 600,000 Americans of all ages.
The future of epilepsy research depends on attracting the best scientific minds to the study of seizures and funding innovative research. To do just that, the Epilepsy Foundation offers a series of training grants and fellowships in basic, clinical and behavioral science to scientists at the start of their careers.
Each year the Foundation invites research investigators to apply for grants and fellowships to test new ideas and follow new research leads. The applications, more than 100 in an average year, are ranked according to merit by a blue ribbon panel of research scientists, and funded according to available resources.
These grants and fellowships, awarded to new scientists at the nation's leading research institutes, have in many cases been the first steps in a lifetime commitment to solving the medical and scientific puzzle of why epilepsy develops and how it can be treated or prevented.
Targeted Research Initiatives
The Epilepsy Foundation periodically offers funding opportunities to established investigators for targeted research initiatives.
Current targeted initiatives focus on cognitive and psychiatric aspects, health outcomes, morbidity and mortality, youth, women and severe symptomatic forms of epilepsy.
The mission of the Epilepsy Foundation - New Therapy Commercialization Grants Program is to drive the development of new therapies for epilepsy, accelerating the advancement of research from the laboratory to the patient. The Foundation funds innovative senior level research projects led by the nation's leading scientists with the potential to discover new treatment options and ultimately a cure.
The Epilepsy Innovation Seal of Excellence awards are, like the New Therapy Commercialization Grants (NTCG) program above, designed to accelerate the advancement of research from the laboratory to the patient. SEALs are provided to academic and commercial groups worldwide. The program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. Drug development may be stimulated at the early phases leading to an IND. The Epilepsy Innovation Seal of Excellence award is not primarily a grant program. The program provides a competitive, in-depth review by the Scientific and Business Advisory Boards, an actual SEAL that may be used by the awardee to generate interest in the project, and a one-time $25,000 grant for the research. The SEAL is award for one year, renewable upon application, for up to a total of four years; the funding for this award is only provided for the first year. The applicants will typically have a research budget of between 1 and $5M for the overall project--amounts that currently exceed the resources of the Epilepsy Foundation. The Epilepsy Foundation will assist the awardees in finding funds for the selected projects. http://www.epilepsy.com/etp/research_programs.
Read more about funding opportunities.
View the Epilepsy Foundation research awards from recent years